Results 131 to 140 of about 19,467 (279)

Progestin intrauterine devices versus copper intrauterine devices for emergency contraception. [PDF]

open access: yesCochrane Database Syst Rev, 2023
Ramanadhan S   +6 more
europepmc   +1 more source

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Reproductive Tract Infections among Women in Pakistan: An Urban Case Study [PDF]

open access: yes
Reproductive tract infections (RTIs) among women—despite being common and having grave consequences—are not given much attention by policy-makers and health planners.
Durr-e-Nayab
core  

Seventh Åland Island Meeting on von Willebrand Disease

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction The seventh Åland Island Meeting on von Willebrand Disease (VWD) was held on the Åland archipelago in Finland, from 26 to 28 September 2024. Aim The meeting brought together experts in the field of VWD from around the world to share the latest advances and knowledge in VWD.
Riitta Lassila   +17 more
wiley   +1 more source

Effects of propolis coating on antibacterial resistance of intrauterine devices [PDF]

open access: yes
Intrauterine devices (IUDs) are widely used in preventing fertilization as contracepting devices. In market, they are produced as T-shaped polyethylene (or propylene) and metal (especially copper) composites.
Uzun, L.   +3 more
core   +3 more sources

Displaced intrauterine contraceptive device: a multidisciplinary approach

open access: yesJournal of the Pakistan Medical Association
Implantation of intrauterine contraceptive devices (IUCDs) has become a common method of family planning. Very few patients experience any complication, which is why it is regarded as a safe method.
Kinza Alam   +5 more
doaj   +1 more source

Symptoms, Diagnosis, and Treatment for Women and Girls With Hemophilia: A Narrative Review

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Hemophilia is an X‐linked bleeding disorder previously thought to present only in men. This sentiment is rapidly changing as the information around women and girls’ experiences of bleeding symptoms has evolved, sparking intense discussion among researchers, clinicians, patients, and patient advocates regarding appropriate ...
Sam Hirniak   +6 more
wiley   +1 more source

Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices. [PDF]

open access: yesObstet Gynecol, 2023
Fassett MJ   +19 more
europepmc   +1 more source

Tolerability of hormonal treatments in acute hepatic porphyria patients

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Acute hepatic porphyria (AHP) flares have been associated with female hormones and the use of hormonal treatments. Women with AHP are traditionally advised to avoid exogenous oestrogen and progesterone, limiting options for contraception and management of menorrhagia, dysmenorrhoea and menopausal symptoms.
Andjela Arandjelovic   +2 more
wiley   +1 more source

New developments in intrauterine device use: focus on the US [PDF]

open access: yes, 2016
Anita L Nelson,1 Natasha Massoudi2 1Department of Obstetrics and Gynecology, Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, CA, USA; 2American University of the Caribbean School
Nelson AL, Massoudi N
core  

Home - About - Disclaimer - Privacy